Replies to post #430394 on Amarin Corp Plc (AMRN)

[seve333]

It is almost like denner does not even care and maybe he doesnt given its such a small holding for him. I have sold half my position and almost made all the losses back in another stock so far in like three months. Given how on fire the market is right now this is such dead money I wish I had sold it all and bought back in like six months later. I would have basically made up all my losses in AMRN. The conference was pointless but that is no surprise none of us expected anything given the track record of denner the last almost two years.

[Birdbrain Ideas]

I can't really disagree. But it was interesting that part of their presentation was an indictment of the KM era, showing how we raced into Europe after Judge Du's ruling and threw money away on efforts like Germany that were empty holes, hiring staff and creating a structure to sell the product only to have it collapse or grow so slowly that the "seed" money wasn't sensible.

I think part of the purpose today was to portray the company as innovative and as nimble as a startup, getting a lot of bang for the buck. It left me wondering if Amarin might be able to make money in the future by advising other small pharmaceuticals how to bring a new drug quickly to market without spending much money. The knowledge the company is gaining must have some value for others who would be willing to pay Amarin for the expertise.

I thought that's what Amarin believed it was getting when it hired KM, someone who supposedly knew how to market a new drug in Europe. But what the company probably learned was that he knew how to do it if he had all the marketing and money that a company like Merck provides, but he probably didn't know how to launch a drug in multiple markets with a shoestring budget and uncertain prospects.